Silymarin as a Therapeutic Agent for Hepatocellular Carcinoma: A Multi-Approach Computational Study

Silymarin as a Therapeutic Agent for Hepatocellular Carcinoma: A Multi-Approach Computational Study

Background: Hepatocellular carcinoma (HCC) is a prevalent and lethal form of liver cancer with limited treatment options. Silymarin, a flavonoid complex derived from milk thistle, has shown promise in liver disease treatment due to its antioxidant, anti-inflammatory, and anticancer properties. This...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ouided Benslama, Sabrina Lekmine, Hamza Moussa, Hichem Tahraoui, Mohammad Shamsul Ola, Jie Zhang, Abdeltif Amrane
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Metabolites
Subjects:	silymarin hepatocellular carcinoma network pharmacology molecular docking molecular dynamics simulations
Online Access:	https://www.mdpi.com/2218-1989/15/1/53
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preliminary Data on <i>Silybum marianum</i> Metabolites: Comprehensive Characterization, Antioxidant, Antidiabetic, Antimicrobial Activities, LC-MS/MS Profiling, and Predicted ADMET Analysis
by: Sabrina Lekmine, et al.
Published: (2025-01-01)

The effect of silymarin on ischemia-reperfusion injury in skeletal muscles of rats
by: Abdullah Ozer, et al.
Published: (2024-03-01)

Network pharmacology and in silico investigation into the therapeutic potential of phytoconstituents of Peucedanum ostruthium as anti-tubercular agents
by: Neeru Bhanwala, et al.
Published: (2025-03-01)

Silymarin: a promising modulator of apoptosis and survival signaling in cancer
by: Ujjawal Sharma, et al.
Published: (2025-01-01)

Polyhydroxyalkanoates Biopolymer Production by Moderately Halophilic Paracoccus onubensis Strain E3: Extraction, Characterization and Synergistic Activity with Sorafenib Drug against Hepatocellular Carcinoma through Molecular Docking Approach
by: Hend A. Hamedo, et al.
Published: (2025-01-01)

Essential oils from Amorpha fruticosa against hepatocellular carcinoma based on network pharmacology
by: Yixian Liu, et al.
Published: (2025-01-01)

Evaluating the therapeutic effect of different forms of silymarin on liver status and expression of some genes involved in fat metabolism, antioxidants and anti‐inflammatory in older laying hens
by: Samira Faryadi, et al.
Published: (2024-11-01)

Effects of Baicalin on Gout Based on Network Pharmacology, Molecular Docking, and in vitro Experiments
by: Liu C, et al.
Published: (2025-02-01)

Exploring the antiviral potential of shikimic acid against Chikungunya virus through network pharmacology, molecular docking, and in vitro experiments
by: Jialiang Xin, et al.
Published: (2025-01-01)

Post-treatment of rat aflatoxicosis by camel milk and silymarin
by: Nahla H. Hassaneen, et al.
Published: (2025-02-01)

Exploring the multi-targeted mechanism of Saikosaponin A in prostate cancer treatment: a network pharmacology and molecular docking approach
by: Genbao Zhu, et al.
Published: (2025-02-01)

Integrating single-cell RNA-Seq and bulk RNA-Seq data to explore the key role of fatty acid metabolism in hepatocellular carcinoma
by: Hua Dai, et al.
Published: (2025-01-01)

Beneficial Effect of Fenofibrate in Combination with Silymarin on Parameters of Hereditary Hypertriglyceridemia-Induced Disorders in an Animal Model of Metabolic Syndrome
by: Jan Soukop, et al.
Published: (2025-01-01)

APT imaging of hepatocellular carcinoma signals an effective therapeutic response in advance of tumor shrinkage
by: Xiaojing Wang, et al.
Published: (2024-12-01)

Based on network pharmacology and molecular docking to study the mechanisms of active ingredients of ginseng in the treatment of atopic dermatitis
by: BU Jialiang, et al.
Published: (2025-01-01)

Metabolic profiles and potential antioxidant mechanisms of hawk tea
by: Sixia Jiang, et al.
Published: (2025-01-01)

CADD-based discovery of novel oligomeric modulators of PKM2 with antitumor activity in aggressive human glioblastoma models
by: Maia Cabrera, et al.
Published: (2025-02-01)

Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics
by: Jibon Kumar Paul, et al.
Published: (2025-01-01)

Targeting aldose reductase using natural African compounds as promising agents for managing diabetic complications
by: Miriam E. L. Gakpey, et al.
Published: (2025-02-01)

Clinical study, network pharmacology, and molecular docking of Kunxian capsule in treating idiopathic membranous nephropathy
by: Jia Lv, et al.
Published: (2025-02-01)

Investigation of Scutellaria Barbata’s immunological mechanism against thyroid cancer using network pharmacology and experimental validation
by: Gen Ouyang, et al.
Published: (2025-01-01)

Bridging Molecular Docking to Molecular Dynamics to Enlighten Recognition Processes of Tailored D-A/D-A-D Types' AIEgens with HSA/BSA
by: Harun Nalçakan, et al.
Published: (2023-09-01)

Elucidating the metabolic mechanisms and active constituents of ZuoGui Wan in combatting postmenopausal osteoporosis: A metabolomics and network pharmacology approach
by: Yanchen Feng, et al.
Published: (2025-02-01)

Phytochemical screening and neuro-pharmacological activity of Mimosa pudica flowers: Integrating in vitro, in silico and in vivo approaches
by: Fahmida Alam, et al.
Published: (2025-02-01)

Synthesis and evaluation of nitrochromene derivatives as potential antileishmanial therapeutics through biological and computational studies
by: Niloofar Javid, et al.
Published: (2025-01-01)

Elucidating the Mechanism of Action of Umami-Enhancing Peptides Derived from Chicken Based on Molecular Simulation
by: ZHANG Jingcheng, HE Wei, LIANG Li, ZHANG Yuyu
Published: (2024-12-01)

Proposing a new anti-Covid-19 agent by using molecular docking and dynamics simulations
by: Izabella Rodrigues Fonseca da Silva, et al.
Published: (2025-01-01)

CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent
by: Anchal Sharma, et al.
Published: (2025-02-01)

Mechanism of salvianolic phenolic acids and hawthorn triterpenic acids combination in intervening atherosclerosis: network pharmacology, molecular docking, and experimental validation
by: Qu Zhai, et al.
Published: (2025-01-01)

Anti-obesity mechanisms elucidation of essential oil components from Artemisiae Argyi Folium (Aiye) by the integration of GC-MS, network pharmacology, and molecular docking
by: Yongxiang Liu, et al.
Published: (2025-12-01)

Discovery of novel PRMT1 inhibitors: a combined approach using AI classification model and traditional virtual screening
by: Jungan Zhang, et al.
Published: (2025-01-01)

Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases
by: Jialian Lv, et al.
Published: (2025-02-01)

Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysis
by: Rahil Ummar Faruk Abbu, et al.
Published: (2025-02-01)

Naringenin inhibits lipid accumulation by activating the AMPK pathway in vivo and vitro
by: Xiaoyu Cai, et al.
Published: (2023-07-01)

In silico (Eco)toxicology and molecular docking of halogenated and oxygenated rotenoid derivatives
by: Damião Sampaio de Sousa, et al.
Published: (2023-12-01)

QSAR modelling and docking analysis of some thiazole analogues as alfa-glucosidase inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2019-06-01)

Curcumin: Synthesis optimization and in silico interaction with cyclin dependent kinase
by: Ahmed Mahmood, et al.
Published: (2017-09-01)

A Theoretical Study on the Efficacy and Mechanism of Combined YAP-1 and PARP-1 Inhibitors in the Treatment of Glioblastoma Multiforme Using Peruvian Maca <i>Lepidium meyenii</i>
by: Albert Gabriel Turpo-Peqqueña, et al.
Published: (2025-01-01)

Deciphering CSU pathogenesis: Network toxicologyand molecular dynamics of DOTP exposure
by: Fang Cao, et al.
Published: (2025-02-01)

Improving the binding affinity of plastic degrading cutinase with polyethylene terephthalate (PET) and polyurethane (PU); an in-silico study
by: Deves Sabari V L, et al.
Published: (2025-01-01)